Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites—current status

https://doi.org/10.1016/0969-8051(93)90082-6Get rights and content

Abstract

The status of the radiochemical development and biological evaluation of radioligands for PET studies of central benzodiazepine (BZ) receptors and the so-called peripheral benzodiazepine binding sites, here discriminated and referred to as PK binding sites, is reviewed against current pharmacological knowledge, indicating those agents with present value and those with future potential. Practical recommendations are given for the preparation of two useful radioligands for PET studies, [N-methyl-11C]flumazenil for central BZ receptors, and [N-methyl-11C]PK 11195 for PK binding sites. Quality assurance and plasma metabolite analysis are also reviewed for these radioligands and practical recommendations are given on methodology for their performance.

References (185)

  • D. Comar et al.

    The kinetics and displacement of [11C]flunitrazepam in the brain of living baboon

    Eur. J. Pharmacol.

    (1981)
  • E. Costa et al.

    Diazepam binding inhibitor (DBI): a peptide with multiple biological actions

    Life Sci.

    (1991)
  • J.E. Cremer et al.

    The distribution of radioactivity in brains of rats given N-methyl-11C)PK 11195 in vivo after induction of a acortical ischaemic lesion

    Nucl. Med. Biol.

    (1992)
  • C. Crouzel et al.

    Recommendations for a practical production of 11C-Methyl iodide

    Appl. Radiat Isot.

    (1987)
  • L. Deng et al.

    [3H]Muscimol photolabels the γ-aminobutyric acid receptor binding site on a peptide subunit distinct from that labelled with benzodiazepines

    Biochem. Biophys. Res Commun.

    (1986)
  • A. Doble et al.

    Multiple benzodiazepine receptors: no reason for anxiety

    TiPS

    (1992)
  • A. Doble et al.

    Labelling of peripheral-type benzodiazepine binding sites in human brain with 3H)PK 11195: anatomical and subcellular distribution

    Brain Res. Bull.

    (1987)
  • M.-C. Dubroeucq et al.

    Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral benzodiazepine binding sites by a quinolinepropranamide derivative

    Eur. J. Pharmacol.

    (1986)
  • M.J. Duggan et al.

    Biochemical evidence for the existence of γ-aminobutyrateA receptor iso-oligomers

    J. Biol. Chem.

    (1990)
  • F. Fadda et al.

    Protection against ethanol mortality in rats by the imidazobenzodiazepine Ro 15-4513

    Eur. J. Pharmacol.

    (1987)
  • J.J. Frost

    Imaging neuronal biochemistry by emission computed tomography: focus on neuroreceptors

    TiPS

    (1986)
  • K. Fuchs et al.

    Evidence for the existence of several different alpha- and beta- subunits of the GABA/benzodiazepine receptor complex from rat brain

    Neurosci. Lett.

    (1989)
  • K. Fuchs et al.

    Various proteins from rat brain, specifically and irreversibly labeled by [3H]flunitrazepam, are distinct a subunits of the GABAA benzodiazepine receptor complex

    Neurosci. Lett.

    (1988)
  • D.L. Gildersleeve et al.

    Synthesis of a high specific activity [125I]-labeled analog of PK 11195, potential agent for SPECT imaging of the peripheral benzodiazepine binding site

    Nucl. Med. Biol.

    (1989)
  • C. Halldin et al.

    11C-Labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors

    Appl. Radiat. Isot.

    (1988)
  • P. Hantraye et al.

    Central type benzodiazepine binding sites: a positron emission tomography study in the baboon's brain

    Neurosci. Lett.

    (1984)
  • K. Ishiwata et al.

    Synthesis and biodistribution of [11C]fludiazepam for imaging benzodiazepine receptors

    Nucl. Med. Biol.

    (1988)
  • C.A. Klepner et al.

    Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors

    Pharmacol. Biochem. Behaviour

    (1979)
  • S.Z. Langer et al.

    Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes

    Pharmacol. Biochem. Behaviour

    (1988)
  • B. Långström et al.

    The synthesis of [1-11C]-labelled ethyl, propyl, butyl and isobutyl iodides and examples of alkylation reactions

    Appl. Radiat. Isot.

    (1986)
  • D. Le Bars et al.

    The preparation of a carbon-11 labelled neurohormone—[11C]melatonin

    Appl. Radiat. Isot.

    (1987)
  • G. Le Fur et al.

    Differentiation between two ligands for peripheral benzodiazepine binding sites. [3H]Ro 5 4864 and [3H]PK 11195, by thermodynamic studies

    Life Sci.

    (1983)
  • H. Lüddens et al.

    Function and pharmacology of multiple GABAA receptor subunits

    TiPs

    (1991)
  • S.K. Luthra et al.

    Preparation of NCA [1-11C]acid chlorides as labelling agents

    Appl. Radiat. Isot.

    (1990)
  • R.R.H. Anholt et al.

    Peripheral type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats

    J. Pharmacol. Exp. Ther.

    (1985)
  • S. Arbilla et al.

    Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats

    Naunyn-Schmiedeberg's Arch. Pharmacol.

    (1985)
  • L. Autkiewicz-Michaluk et al.

    Purification and characterisation of a protein associated with peripheral-type benzodiazepine binding sites

    J. Biol. Chem.

    (1988)
  • M. Awad et al.

    Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites

    J. Neurochem.

    (1987)
  • W. Banks et al.

    Synthesis of carbon-11 alprazolam. A benzodiazepine receptor agonist

    J. Labelled Cmpd. Radiopharm.

    (1989)
  • W.R. Banks et al.

    Investigations of the in vivo stability and the biodistribution of alprazolam a benzodiazepine receptor agonist

    J. Labelled Cmpd. Radiopharm.

    (1991)
  • M.L. Barbaccia et al.

    DBI (diazepam binding inhibitor): the precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives and clinical implications

    Neurochem. Res.

    (1990)
  • H.F. Beer et al.

    In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors

    J. Nucl. Med.

    (1990)
  • J. Bénavidès et al.

    Peripheral-type benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization

    Arch. Int. Pharmacodyn.

    (1983)
  • J. Bénavidès et al.

    Labelling of ‘peripheral-type’ benzodiazepine binding sites in the rat brain using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localisation

    J. Neurochem.

    (1983)
  • J. Bénavidés et al.

    Imaging of human brain lesion with an ω3 site radioligand

    Ann. Neurol.

    (1988)
  • M. Bergström et al.

    Peripheral benzodiazepine binding sites in human gliomas evaluated with positron emission tomography

    Acta Radiologica (Scand.) (Suppl.)

    (1986)
  • C.F. Beyer et al.

    Photoaffinity labelling and partial purification of the mitochondrial benzodiazepine receptor

    FASEB J.

    (1988)
  • K.L. Black et al.

    Imaging of brain tumors using peripheral benzodiazepine receptor ligands

    J. Neurosurg.

    (1989)
  • E.P. Bonetti et al.

    An azido analogue of the benzodiazepine antagonist Ro 15-1788 (Ro 15-4513) behaves as a partial inverse benzodiazepine agonist

    Neurosci. Lett.

    (1984)
  • E.P. Bonetti et al.

    The partial inverse benzodiazepine agonist Ro 15-4513 antagonizes acute ethanol effects in mice and rats

    Br. J. Pharmacol.

    (1985)
  • Cited by (0)

    A report from a task group organized within the framework of the EEC Concerted Action on “PET Investigations of Cellular Regeneration and Degeneration.”

    View full text